If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | ||
![]() Contact DermatitisVolume 49 Issue 3, Pages 155 - 157 Published Online: 15 Dec 2003 © 2010 John Wiley & Sons A/S
Abstract | References | Full Text: HTML, PDF (Size: 65K) | Related Articles | Citation Tracking Systemic acyclovir reaction subsequent to acyclovir contact allergy: which systemic antiviral drug should then be used? Copyright Blackwell Munksgaard 2003 – INR KEYWORDS acyclovir • allergic contact dermatitis • antiviral drugs • cross-reactions • cutaneous adverse drug reactions • medicaments • oral provocation test • patch tests • systemic ABSTRACTAllergic contact dermatitis caused by acyclovir is rare. We report the 5th case of systemic acyclovir reaction subsequent to acyclovir contact dermatitis, with investigations made to determine an alternative antiviral treatment. A 23-year-old woman, after dermatitis while using Zovirax® cream, went on to develop urticaria after oral acyclovir. Patch tests were performed with the components of Zovirax® cream (acyclovir, propylene glycol and sodium lauryl sulfate) and with other antiviral drugs. Patch tests were positive to Zovirax® cream, acyclovir, valacyclovir and propylene glycol. Patch and prick tests with famciclovir were negative, but its oral administration caused an itchy erythematous dermatitis on the trunk and extremities. Our patient developed a systemic acyclovir reaction subsequent to acyclovir allergic contact dermatitis, with cross-reactions to valacyclovir and famciclovir. Their common chemical structure is the 2-aminopurine nucleus. It is probably this part of the molecule that provokes both contact allergy and systemic reactions. The only antiviral drugs not having this core are foscarnet and cidofovir, and these could therefore be alternatives. Accepted for publication 13 October 2003 |